Robert Glanzman und Clene - Info zur Person

(1 - 31 von 45

)

CLNN.OQ - Clene Inc. | Stock Price & Latest News | Reuters

www.reuters.com

Robert Glanzman: Chief Medical Officer. Reed Neil Wilcox: Director, Co-Founder. Jonathan T. Gay: Independent Director. Shal Jacobovitz: Independent Director. › companies

Ginkgo Bioworks Acquires Adaptive Laboratory Evolution ...

dcnewsstation.com

vor 6 Stunden — Robert Glanzman, M.D., FAAN, Clene's Chief Medical Officer, said, “We are very pleased to see a survival benefit in a broad population of ... › ginkgo...

ARUP Expert Joins Industry Peers to Explore How COVID

www.aruplab.com

— ... Experimental Pathology; Robert Glanzman, MD, chief medical officer of Clene Nanomedicine; and James McCullough, CEO of RenalytixAI. › news

CNM-Au8 Found to Lessen Vision Problems in MS Patients in ...

multiplesclerosisnewstoday.com

— ... entire central nervous system,” Robert Glanzman, MD, Clene's chief medical officer, said in a company webcast announcing the results. › ...

Robert Glanzman M.D., FAAN | Clene Inc.

clene.com

› member › robe...

Clene Nanomedicine Announces First Patients Enrolled in ...

markets.businessinsider.com

— Robert Glanzman, MD, FAAN, Clene's Chief Medical Officer, further commented, "We at Clene are very excited to be partnering with the Healey ... › ...

Chelsea Worldwide Inc. - Business Contracts | Justia

contracts.justia.com

); Amendment to Employment Agreement, dated February 1, 2022, by and between Clene Inc. and Dr. Robert Glanzman (Filed With SEC on February 2, 2022) ... › chelse...

Gold Coast diagnostic criteria: Implications for ALS diagnosis ...

onlinelibrary.wiley.com

von S Vucic · · Zitiert von: 4 — Robert Glanzman MD,. Clene, Nanomedicine, Salt Lake City, Utah, USA. Search for more papers by this author · Kasper C. D. Roet PhD,. › mus

Clene Inc. - cloudfront.net

d18rn0p25nwr6d.cloudfront.net

— amyotrophic lateral sclerosis,” said Dr. Robert Glanzman, MD FAAN, Clene's Chief Medical Officer. “We look forward to the continued ... › CIK

Clene Inc Current Report 8-K

sec.report

— Robert Glanzman , MD FAAN Chief Medical Officer Clene Nanomedicine, Inc (January 2020); FPFV Jan ; 45 of 42 enrolled (Nov ... › Clene Inc.

HEALEY ALS Platform Trial - Neuromuscular Division Update

www.massgeneral.org

— Robert Glanzman, MD, FAAN. Chief Medical Officer. Clene Nanomedicine, Inc. Michael Hotchkin. Chief Development Officer. › als › presentations

Twitter-Nachrichten: Clene Nanomedicine on Twitter: "Meet Robert Glanzman, MD FAAN ...

› status

Clene Nanomedicine to Present Data from Phase 2 Multiple

www.globenewswire.com

— Presenter: Robert Glanzman, M.D., FAAN, Chief Medical Officer of Clene. Abstract Number: Poster Number: P100 Poster Session: PS1. › ...

Clene Nanomedicine to Present Data from Phase 2 Multiple ...

finance.yahoo.com

— Presenter: Robert Glanzman, M.D., FAAN, Chief Medical Officer of Clene. The posters will be available on demand via the conference portal ... › news

Robert Glanzman - Roles at Clene Nanomedicine - The Org

theorg.com

› org › org-chart

Robert Glanzman - Biographie

www.zonebourse.com

Presently, Robert Glanzman is Chief Medical Officer of Clene, Inc. In the past he occupied the position of Chief Medical Officer of GeNeuro SA , Vice...

Robert Glanzman - CLNN / Clene Inc. - Insider Trade Report - Fintel

fintel.io

› clnn › glanzman-r...

ACTRIMS - IMSVISUAL

www.imsvisual.org

Robert Glanzman, Clene Nanomedicine, Inc. 1:35pm-1:45pm, Functional Connectivity Predicts MS Patients' Impairment Using An Ensemble Model Applied With A ... › tag › ac...

ALS Trials | ALS Clinical Research - NEALS ALS Consortium

www.neals.org

Robert Glanzman, MD Austin Rynders Australia. Full Study Summary:. › als-trials

CLNN | Clene Inc. Company Profile & Executives - WSJ

www.wsj.com

Morgan R. Brown Chief Financial & Accounting Officer. Mark G. Mortenson Chief Science Officer. Robert Glanzman Chief Medical Officer. › CLNN › co...

Clene Sees Path Forward For ALS Candidate Despite Late ...

scrip.pharmaintelligence.informa.com

vor 2 Stunden — ... NASDAQ to close at $2.01 on 3 October, chief medical officer Robert Glanzman claimed the data supported advancement of the 30mg dose. › ...

Clene claims MS drug win, but data leaves questions

www.fiercebiotech.com

... MS as adjunctive therapy to immunomodulatory [disease-modifying therapies],” Clene's chief medical officer Robert Glanzman, M.D., said in a statement. › cl...

Clene claims its PhII MS trial, half its intended size ECHEMI

www.echemi.com

Robert Glanzman. With the primary outcome results, the company is already planning a late-stage trial, CMO Robert Glanzman said on the investor call. › clene-cl...

Clene clobbered on new failure in Healey ALS Platform trial

www.thepharmaletter.com

vor 3 Stunden — Robert Glanzman, Clene's chief medical officer, said: “We are very pleased to see a survival benefit in a broad population of people who had ... › ...

EX SEC.gov

www.sec.gov

... “Amendment””) is made effective as of February 1, 2022, by and among Clene Inc., a Delaware corporation (“Company”), and Robert Glanzman (“Executive”). › clnn-ex10_5

Home treatment of mild/moderate COVID Europe PMC

europepmc.org

von E Frohman · — Robert Glanzman: Is the Chief Medical Officer for Clene Nanomedicine. Sarah Rugheimer: Has nothing to disclose. › pmc › pm...

Steven Glanzman - Chief Financial Officer at - Salesgear

www.salesgear.io

Michael Glanzman. Partner at Smith Gambrell & Russell. Email. View. Phone. View. View Profile. Robert Glanzman. Chief Medical Officer at Clene Nanomedicine. › steven-g...

TechNation Radio Podcast: Episode The Science

podcasts.apple.com

Rob Etherington and Robert Glanzman from Clene Nanomedicine talk about using trillions of gold nanocrystals now being tested in advanced clinical trials. › podcast

Clene Nanomedicine's RESCUE-ALS Phase 2 Results ...

www.biospace.com

— Presenter: Dr. Robert Glanzman, MD FAAN, Chief Medical Officer of Clene Session Details: Live Poster Session A, CLT-14. Time: Tuesday, Dec. › releases

Clene claims its PhII MS trial, half its Endpoints News

endpts.com

— With the primary outcome results, the company is already planning a late-stage trial, CMO Robert Glanzman said on the investor call. › clene-claims-it...

Phase 2 remyelination trial yields 'intriguing' interim results

www.mdedge.com

— I'm just here to tell you that we have intriguing data,” said Robert Glanzman, MD, chief medical officer of Clene Nanomedicine, ... › article

Alle Infos zum Namen "Robert Glanzman"

Verwandte Suchanfragen zu Robert Glanzman

David Leppert
Ludwig Kappos
Martin Schneble

Hans Martin Schneble
Hans Martin

Personen
Vorname "Robert" (66197)
Name "Glanzman" (7)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Robert Glanzman und Clene Person-Info